There were only 12 Mexican pharmaceutical companies engaged in the manufacture of solvents and simple formulas in the XX century . In this context they also had some providers , especially from Europe , who were responsible for the imports of drugs .

By May 12 , 1945 , a group of businessmen were called in order to create the National Association of Manufacturers of Pharmaceutical and Medicinal Chemicals , a direct predecessor of what is now the National Association of Pharmaceutical Manufacturers , Ac ( ANAFAM ). ANAFAM has served as a representative of the pharmaceutical industry , mostly in the Mexican capital , as well as some established companies in the international market , which are actively involved and recognized in the supply of medicines both in the public sector ( government ) and the private market .

Our associates cover a production of 60 percent of the requirements of the public sector , 18 percent of the needs of the private market , which represents a supply of 40 percent of the medicines consumed in the country .

Investing in research and development ( R & D ) has been one of ANAFAM ’ S greatest efforts , with a dedicated 15 percent of the total investment in this field .

ANAFAM is composed of 28 companies , which together make up a workforce of over 20,000 employees . One of ANAFAM ’ s major objectives is that in Mexico the principle active ingredients

58 November 2014

Healthcare Magazine November 2014 | Page 58

There were only 12 Mexican pharmaceutical companies engaged in the manufacture of solvents and simple formulas in the XX century . In this context they also had some providers , especially from Europe , who were responsible for the imports of drugs .